CMV-Related Hemorrhagic Retinal Vasculitis in a Multiple Myeloma Patient on Daratumumab Therapy: A Case Report
Authors
Matthaeus Ware•Yasmin Motekalem•Peng Yan
Journal
Ocular Immunology and Inflammation
Published
November 25, 2024
Abstract
To report a case of cytomegalovirus (CMV)-related hemorrhagic retinal vasculitis in a patient with multiple myeloma (MM) on daratumumab, a trial cereblon E3 ligase modulatory drug (CELMoD), dexamethasone, and acyclovir, and discuss clinical implications for CMV prophylaxis.
Supporters
Support the authors with ResearchCoin
Topics
DOI
License
Unknown License